课题基金 / 基金详情

项目摘要

项目成果

HENRY J KAMINSKI的其他基金

相似基金

相关文献

中文摘要
翻译
MGNet的行政核心用于支持RDCRN的所有活动,以优化 临床研究绩效和职业提升活动。我们通过提供员工来做到这一点 侧重于促进与研究启动、执行和结束相关的所有活动 活动临床研究协调员培训、生物统计分析、临床 将提供试验开发和免疫学研究。MGNet的领导层 包括行政协调员、临床医生、翻译科学家、免疫学家、患者 倡导团体领导和患者。该合作小组将提供监督和 推动流程改进,并制定战略计划,以确保长期的可行性 关于MGNet行政核心将制定重点项目,超越目前的项目 建议加强MGNet站点以外的临床试验准备,并与行业合作, 优化MG临床试验的性能。MGNet所有成员的共同目标是1) 提供一种结构,以加强发现和验证治疗反应性或- 最终目标是增强治疗开发的预测标志物,2)改善 临床试验结果指标和基础设施,以及3)提高临床试验质量 研究MG。随着MGNet的成熟,
英文摘要
The Administrative Core of MGNet serves to support all activities of the RDCRN to optimize clinical research performance and career enhancement activities. We do so by provision of staff focused on facilitation of all activities related to study initiation, performance, and close out activities. Core services for clinical research coordinator training, biostatistical analysis, clinical trial development, and immunological investigations will be provided. The leadership of MGNet includes the administrative coordinator, clinicians, translational scientists, immunologists, patient advocacy group leadership, and patients. This collaborative group will provide oversight and drive process improvement as well as develop a strategic plan to assure the long-term viability of MGNet. Administrative Core will develop focused projects beyond those in the present proposal to enhance clinical trial readiness beyond MGNet sites and partner with industry to optimize the performance of MG clinical trials. The shared goals of all members of MGNet are 1) to provide a structure to enhance discovery and validation of treatment-responsive or – predictive markers with the ultimate goal of enhancing therapeutic development, 2) improve clinical trial outcome measures and infrastructure, and 3) enhance the quality of clinical research for MG. As MGNet matures, the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rare Disease Network for Myasthenia Gravis
  • 批准号:
    10207810
  • 项目类别:
  • 资助金额:
    $149.07万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
Rare Disease Network for Myasthenia Gravis
  • 批准号:
    10437794
  • 项目类别:
  • 资助金额:
    $158.9万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
  • 批准号:
    10437798
  • 项目类别:
  • 资助金额:
    $24.72万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
Rare Disease Network for Myasthenia Gravis
  • 批准号:
    9804343
  • 项目类别:
  • 资助金额:
    $161.02万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
海外基金